Skip to content
DraconiticResearch
Search Sources API
197,788 studies31 sourcesUpdated 40 min ago
Peer-reviewedCC BYMedicine international

Synergistic antimycobacterial activity of Piper longum and Cressa cretica extracts and their effects on the expression of rpoB, gyrA and gyrB genes in Mycobacterium tuberculosis.

5 affiliations
  1. 1ICMR-National Institute of Research in Tribal Health (NIRTH), Jabalpur, Madhya Pradesh 482003, India.
  2. 2Madhya Pradesh Medical Science University, Jabalpur, Madhya Pradesh 482003, India.
  3. 3All India Institute of Medical Sciences Chhattisgarh, Raipur, Chhattisgarh 492099, India.
  4. 4ICMR-National Institute of Traditional Medicine, Belagavi, Karnataka 590010, India.
  5. 5Vels Institute of Science, Technology and Advanced Studies, Chennai, Tamil Nadu 600035, India.

Abstract

Tuberculosis (TB) remains one of the leading causes of mortality from infectious diseases worldwide, with the increasing prevalence of multidrug-resistant TB posing a major challenge to effective disease control. Combination therapy has become a key strategy for improving treatment efficacy, while minimizing the emergence of drug resistance. In the present study, the synergistic antimycobacterial activity of methanolic extracts of Piper longum (P. longum) and Cressa cretica (C. cretica) against Mycobacterium tuberculosis (M. tuberculosis; H37Rv) was investigated using a two-dimensional checkerboard assay. In addition, the effects of the individual extracts on the expression of the rpoB, gyrA and gyrB genes, which are associated with transcription and DNA replication, were evaluated using reverse transcription-quantitative PCR (RT-qPCR). The minimum inhibitory concentrations (MICs) of P. longum and C. cretica were 125 and 250 µg/ml, respectively. When used in combination, the MIC of P. longum decreased to 7 µg/ml, while that of C. cretica decreased to 10 µg/ml, corresponding to 18- and 25-fold reductions, respectively. The combination exhibited potent synergistic activity with a fractional inhibitory concentration index of 0.096. Phytochemical screening revealed the presence of several bioactive constituents, including alkaloids, phenolic compounds, flavonoids, tannins, terpenoids, glycosides, sterols, carbohydrates and proteins. RT-qPCR demonstrated that treatment with the plant extracts altered the expression profiles of rpoB, gyrA and gyrB during different stages of bacterial growth, with the most prominent transcriptional changes were observed between 24 and 72 h following treatment. On the whole, these findings demonstrate that P. longum and C. cretica exhibit significant synergistic antimycobacterial activity against M. tuberculosis and influence the expression of genes involved in essential cellular processes. Further bioactivity-guided fractionation, the identification of active phytochemicals, mechanistic investigations, cytotoxicity evaluation and in vivo studies are required to validate their potential as complementary therapeutic candidates for tuberculosis.

Related

  1. Mycobacterium tuberculosis gene expression dynamics in host environments with single-cell resolution
    Beren Aylan, Laure Botella, Pierre Santucci +5
    Cell Reports MethodsPeer-reviewedCC BY 4.0Full textProteomics & metabolomicsMicrobiologyHAL
  2. CRTAM enhances T cell antimicrobial activity, particularly CD8+ T cells, against Mycobacterium tuberculosis infection
    Ying Peng, Juechu Wang, Xuejiao Ji +8
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textInfectious diseaseDOAJCrossref
  3. Diethyl fumarate exhibits potent activity against differentially culturable Mycobacterium tuberculosis persisters.
    Amelie J Herbert, Obolbek Turapov, Fraser MacDonald +5
    Frontiers in cellular and infection microbiologyPeer-reviewedCC BYFull textInfectious diseaseEurope PMC
  4. Identification and serological characterization of MtbAg1073, a conserved Mycobacterium tuberculosis complex antigen recognized in active tuberculosis
    Khouanheuane Sengkhamyong, Pheophet Lamaningao, Takaki Shimono +2
    Environmental Health and Preventive MedicinePeer-reviewedCC BY 4.0Full textInfectious diseaseJ-STAGE
  5. Commentary: A proteome-wide atlas of humoral immunity to Mycobacterium tuberculosis across the spectrum of disease
    Samreen Fatima
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textInfectious diseaseCrossrefEurope PMC
BibTeX
@article{tamrakar2026synergistic,
  title = {{Synergistic antimycobacterial activity of Piper longum and Cressa cretica extracts and their effects on the expression of rpoB, gyrA and gyrB genes in Mycobacterium tuberculosis.}},
  author = {Vaibhav Kumar Tamrakar and Jyothi Bhat and Nitish Singh Parihar and Rajasubramaniam Shanmugam},
  journal = {Medicine international},
  year = {2026},
  month = oct,
  doi = {10.3892/mi.2026.345},
  url = {https://europepmc.org/article/MED/42948277},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Synergistic antimycobacterial activity of Piper longum and Cressa cretica extracts and their effects on the expression of rpoB, gyrA and gyrB genes in Mycobacterium tuberculosis.
AU  - Vaibhav Kumar Tamrakar
AU  - Jyothi Bhat
AU  - Nitish Singh Parihar
AU  - Rajasubramaniam Shanmugam
PY  - 2026
DA  - 2026/10/13
JO  - Medicine international
DO  - 10.3892/mi.2026.345
UR  - https://europepmc.org/article/MED/42948277
AB  - Tuberculosis (TB) remains one of the leading causes of mortality from infectious diseases worldwide, with the increasing prevalence of multidrug-resistant TB posing a major challenge to effective disease control. Combination therapy has become a key strategy for improving treatment efficacy, while minimizing the emergence of drug resistance. In the present study, the synergistic antimycobacterial activity of methanolic extracts of Piper longum (P. longum) and Cressa cretica (C. cretica) against Mycobacterium tuberculosis (M. tuberculosis; H37Rv) was investigated using a two-dimensional checkerboard assay. In addition, the effects of the individual extracts on the expression of the rpoB, gyrA and gyrB genes, which are associated with transcription and DNA replication, were evaluated using reverse transcription-quantitative PCR (RT-qPCR). The minimum inhibitory concentrations (MICs) of P. longum and C. cretica were 125 and 250 µg/ml, respectively. When used in combination, the MIC of P. longum decreased to 7 µg/ml, while that of C. cretica decreased to 10 µg/ml, corresponding to 18- and 25-fold reductions, respectively. The combination exhibited potent synergistic activity with a fractional inhibitory concentration index of 0.096. Phytochemical screening revealed the presence of several bioactive constituents, including alkaloids, phenolic compounds, flavonoids, tannins, terpenoids, glycosides, sterols, carbohydrates and proteins. RT-qPCR demonstrated that treatment with the plant extracts altered the expression profiles of rpoB, gyrA and gyrB during different stages of bacterial growth, with the most prominent transcriptional changes were observed between 24 and 72 h following treatment. On the whole, these findings demonstrate that P. longum and C. cretica exhibit significant synergistic antimycobacterial activity against M. tuberculosis and influence the expression of genes involved in essential cellular processes. Further bioactivity-guided fractionation, the identification of active phytochemicals, mechanistic investigations, cytotoxicity evaluation and in vivo studies are required to validate their potential as complementary therapeutic candidates for tuberculosis.
SN  - 2754-3242
SN  - 2754-1304
ER  -